GSK pulls out of $20 bln race for Pfizer assets
22 Mar GSK pulls out of $20 bln race for Pfizer assets
Posted at 08:02h
in
News
by KMFSLLP
LONDON, March 23 (Reuters) – GlaxoSmithKline said on
Friday it had withdrawn from the race to buy Pfizer’s
consumer healthcare business, which the U.S. drugmaker believes
could be worth as much as $20 billion.
Sorry, the comment form is closed at this time.